Sort   by:  
 Page size 
UnknownIntermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Not available
S-EPMC5889346 | biostudies-literature
UnknownRTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA
Not available
S-EPMC7651338 | biostudies-literature
Unknown"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Not available
S-EPMC10713691 | biostudies-literature
UnknownA randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
Not available
S-EPMC7229248 | biostudies-literature
UnknownLarge-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness.
Not available
S-EPMC5510175 | biostudies-literature
UnknownNew loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk.
Not available
S-EPMC4740398 | biostudies-literature
UnknownGenome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Not available
S-EPMC10790310 | biostudies-literature
UnknownDeterminants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
Not available
S-EPMC10473572 | biostudies-literature
UnknownAssessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study.
Not available
S-EPMC6113773 | biostudies-literature
UnknownAssociation of Metformin With the Development of Age-Related Macular Degeneration.
Not available
S-EPMC9936345 | biostudies-literature
Sort   by:  
 Page size